BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wiazzane N, Chargari C, Plancher C, Tamburini J, Asselain B, Fourquet A, Bouscary D, Kirova YM. Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study. World J Radiol 2013; 5(6): 248-252 [PMID: 23807903 DOI: 10.4329/wjr.v5.i6.248]
URL: https://www.wjgnet.com/1949-8470/full/v5/i6/248.htm
Number Citing Articles
1
Fabien Mignot, Antoine Schernberg, Alexandre Arsène-Henry, Marguerite Vignon, Didier Bouscary, Youlia Kirova. Solitary Plasmacytoma Treated by Lenalidomide-Dexamethasone in Combination with Radiation Therapy: Clinical OutcomesInternational Journal of Radiation Oncology*Biology*Physics 2020; 106(3): 589 doi: 10.1016/j.ijrobp.2019.10.043
2
Busong Wang, Jingjing Duan, Liang Zhou. The paradoxical pharmacological mechanisms of lenalidomide and bortezomib in the treatment of multiple myelomaAnti-Cancer Drugs 2021; 32(3): 227 doi: 10.1097/CAD.0000000000001041
3
Richard W. Tsang, Belinda A. Campbell, Jayant S. Goda, Chris R. Kelsey, Youlia M. Kirova, Rahul R. Parikh, Andrea K. Ng, Umberto Ricardi, Chang-Ok Suh, Peter M. Mauch, Lena Specht, Joachim Yahalom. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology GroupInternational Journal of Radiation Oncology*Biology*Physics 2018; 101(4): 794 doi: 10.1016/j.ijrobp.2018.05.009
4
Shan Gao, Yu-tong Wang, Guang-yu Ma, Min-qiu Lu, Bin Chu, Lei Shi, Li-juan Fang, Qiu-qing Xiang, Yue-hua Ding, Li Bao. Solitary bone plasmacytoma: Long-term clinical outcomes in a single centerCurrent Problems in Cancer 2024; 50: 101095 doi: 10.1016/j.currproblcancer.2024.101095